The final report of post-marketing surveillance for cetuximab in colorectal cancer in Japan

被引：0
|
作者：
Yamaguchi, K.
Satoh, T.
Watanabe, T.
Ishiguro, M.
Maruyama, K.
Seriu, T.
Miki, T.
Ito, H.
Sugihara, K.
Sakata, Y.
机构：
[1] Saitama Canc Ctr, Saitama, Japan
[2] Kinki Univ, Sch Med, Osaka 589, Japan
[3] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan
[4] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Tokyo, Japan
[5] Bristol Myers KK, Tokyo, Japan
[6] Merck Serono, Tokyo, Japan
[7] Misawa Municipal Hosp, Misawa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
590
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Japanese Post-marketing Surveillance of Cetuximab (Erbitux) in Patients with Metastatic Colorectal Cancer
    Ishiguro, Megumi
    Watanabe, Toshiaki
    Yamaguchi, Kensei
    Satoh, Taroh
    Ito, Hideyuki
    Seriu, Taku
    Sakata, Yuh
    Sugihara, Kenichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (04) : 287 - 294
  • [2] A JAPANESE POST-MARKETING SURVEILLANCE OF REGORAFENIB IN COLORECTAL CANCER PATIENTS: INTERIM REPORT
    Satoh, Taroh
    Yamazaki, Naoya
    Takikawa, Hajime
    Ito, Hideyuki
    Ito, Yuichiro
    Sakaguchi, Toshiaki
    Yamada, Takashi
    Muro, Kei
    Sugihara, Kenichi
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] POST-MARKETING SURVEILLANCE OF OFLOXACIN IN JAPAN
    YAMADA, A
    NAKAMURA, S
    TAKAHASHI, K
    SAWADA, M
    OKADA, S
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1409 - S1409
  • [4] Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: A final report of effectiveness and safety data
    Matsuoka, K.
    Motoya, S.
    Yamamoto, T.
    Matsuura, M.
    Fujii, T.
    Shinzaki, S.
    Mikami, Y.
    Arai, S.
    Oshima, J.
    Endo, Y.
    Yuasa, H.
    Hoshi, M.
    Sato, K.
    Hisamatsu, T.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1407 - I1409
  • [5] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS IN JAPAN: A FINAL REPORT OF SAFETY AND EFFECTIVENESS DATA
    Matsuoka, Katsuyoshi
    Motoya, Satoshi
    Yamamoto, Takayuki
    Matsuura, Minoru
    Fujii, Toshimitsu
    Shinzaki, Shinichiro
    Mikami, Yohei
    Arai, Shoko
    Oshima, Junichi
    Endo, Yutaka
    Yuasa, Hirotoshi
    Hoshi, Masato
    Sato, Keiko
    Hisamatsu, Tadakazu
    GASTROENTEROLOGY, 2024, 166 (05) : S817 - S818
  • [6] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    CHEMOTHERAPY, 2007, 53 (02) : 85 - 103
  • [7] Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
    Shinozaki, Shohei
    Watanabe, Asuka
    Kimata, Masahiro
    Miyazaki, Makoto
    Maekawa, Shinichiroh
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (01) : 189 - 205
  • [8] Final report of post-marketing survey of panitumumab in Japanese patients with unresectable advanced or recurrent colorectal cancer
    Hamaguchi, Tetsuya
    Boku, Narikazu
    Sugihara, Kenichi
    Kitagawa, Yuko
    Takiuchi, Hiroya
    Hatake, Kiyohiko
    Mum, Kei
    Yoshino, Takayuki
    Yamazaki, Naoya
    Gemma, Akihiko
    Yana, Ikuo
    Ueno, Hiroshi
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [9] Interim analysis of post-marketing surveillance of omalizumab in Japan
    Ohta, Ken
    Yoshisue, Hajime
    Aoki, Yasuo
    Irokawa, Takuro
    Ishigaki, Masahide
    Adachi, Mitsuru
    Miyamoto, Terumasa
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [10] Examination of the safety and effectiveness of budesonide rectal foam for patients with Ulcerative Colitis: Final report of post-marketing surveillance in Japan
    Omori, T.
    Saruta, M.
    Nagaki, A.
    Kuramoto, K.
    Suzuki, Y.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i703 - i703
12345